Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 249K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Wang, R.-F. Articles by Rosenberg, S. A. Search for Related Content PubMed PubMed Citation Articles by Wang, R.-F. Articles by Rosenberg, S. A. Social Bookmarking                            What's this?

Articles

From the National Cancer Institute, Bethesda, Maryland 20892

The infusion of TIL586 along with interleukin-2 into the autologous patient with metastatic melanoma resulted in the objective regression of tumor. A gene encoding a tumor antigen recognized by TIL586 was previously isolated and shown to encode gp75 or TRP-1. Here we report that TRP-2 was identified as a second tumor antigen recognized by a HLA-A31– restricted CTL clone derived from the TIL586 cell line. The peptide LLPGGRPYR epitope was subsequently identified from the coding region of TRP-2 based on studies of the recognition of truncated TRP-2 cDNAs and the HLA-A31 binding motif. This epitope peptide was capable of sensitizing target cells for lysis by a CTL clone at 1 nM peptide concentration. Although some modified peptides could be recognized by the CTL clone, none were found to be better recognized by T cells than the parental peptide. Like other melamona differentiation antigens, TRP-2 was only expressed in melanoma, melanocytes, and retina, but not in other human tissues tested.

¹Abbreviations used in this paper: E/T, effector/target ratio; TIL, tumor infiltrating lymphocyte.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Grinshtein, N., Bridle, B., Wan, Y., Bramson, J. L. (2009). Neoadjuvant Vaccination Provides Superior Protection against Tumor Relapse following Surgery Compared with Adjuvant Vaccination. Cancer Res. 69: 3979-3985 [Abstract] [Full Text]  
• Voo, K. S., Wang, Y.-H., Santori, F. R., Boggiano, C., Wang, Y.-H., Arima, K., Bover, L., Hanabuchi, S., Khalili, J., Marinova, E., Zheng, B., Littman, D. R., Liu, Y.-J. (2009). Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl. Acad. Sci. USA 106: 4793-4798 [Abstract] [Full Text]  
• Kianizad, K., Marshall, L. A., Grinshtein, N., Bernard, D., Margl, R., Cheng, S., Beermann, F., Wan, Y., Bramson, J. (2007). Elevated Frequencies of Self-reactive CD8+ T Cells following Immunization with a Xenoantigen Are Due to the Presence of a Heteroclitic CD4+ T-Cell Helper Epitope. Cancer Res. 67: 6459-6467 [Abstract] [Full Text]  
• Perales, M.-A., Diab, A., Cohen, A. D., Huggins, D. W., Guevara-Patino, J. A., Hubbard, V. M., Engelhorn, M. E., Kochman, A. A., Eng, J. M., Mortazavi, F., Alpdogan, O., Terwey, T. H., Heller, G., Wolchok, J. D., Houghton, A. N., van den Brink, M. R. M. (2006). DNA Immunization against Tissue-Restricted Antigens Enhances Tumor Immunity after Allogeneic Hemopoietic Stem Cell Transplantation. J. Immunol. 177: 4159-4167 [Abstract] [Full Text]  
• Wang, X.-Y., Arnouk, H., Chen, X., Kazim, L., Repasky, E. A., Subjeck, J. R. (2006). Extracellular Targeting of Endoplasmic Reticulum Chaperone Glucose-Regulated Protein 170 Enhances Tumor Immunity to a Poorly Immunogenic Melanoma. J. Immunol. 177: 1543-1551 [Abstract] [Full Text]  
• Flechtner, J. B., Cohane, K. P., Mehta, S., Slusarewicz, P., Leonard, A. K., Barber, B. H., Levey, D. L., Andjelic, S. (2006). High-Affinity Interactions between Peptides and Heat Shock Protein 70 Augment CD8+ T Lymphocyte Immune Responses. J. Immunol. 177: 1017-1027 [Abstract] [Full Text]  
• McWilliams, J. A., McGurran, S. M., Dow, S. W., Slansky, J. E., Kedl, R. M. (2006). A Modified Tyrosinase-Related Protein 2 Epitope Generates High-Affinity Tumor-Specific T Cells but Does Not Mediate Therapeutic Efficacy in an Intradermal Tumor Model. J. Immunol. 177: 155-161 [Abstract] [Full Text]  
• Voo, K. S., Zeng, G., Mu, J.-B., Zhou, J., Su, X.-Z., Wang, R.-F. (2006). CD4+ T-Cell Response to Mitochondrial Cytochrome b in Human Melanoma. Cancer Res. 66: 5919-5926 [Abstract] [Full Text]  
• Cohen, A. D., Diab, A., Perales, M.-A., Wolchok, J. D., Rizzuto, G., Merghoub, T., Huggins, D., Liu, C., Turk, M. J., Restifo, N. P., Sakaguchi, S., Houghton, A. N. (2006). Agonist Anti-GITR Antibody Enhances Vaccine-Induced CD8+ T-Cell Responses and Tumor Immunity.. Cancer Res. 66: 4904-4912 [Abstract] [Full Text]  
• Andersen, M. H., Reker, S., thor Stratem, P., Gehl, J., Geertsen, P., Becker, J. C. (2005). Concomitant Administration of Interleukin-2 During Therapeutic Vaccinations Against Cancer: The Good, the Bad, or the Evil?. JCO 23: 5265-5267 [Full Text]  
• Paschen, A., Song, M., Osen, W., Nguyen, X. D., Mueller-Berghaus, J., Fink, D., Daniel, N., Donzeau, M., Nagel, W., Kropshofer, H., Schadendorf, D. (2005). Detection of Spontaneous CD4+ T-Cell Responses in Melanoma Patients against a Tyrosinase-Related Protein-2-Derived Epitope Identified in HLA-DRB1*0301 Transgenic Mice. Clin. Cancer Res. 11: 5241-5247 [Abstract] [Full Text]  
• Voo, K. S., Peng, G., Guo, Z., Fu, T., Li, Y., Frappier, L., Wang, R.-F. (2005). Functional Characterization of EBV-Encoded Nuclear Antigen 1-Specific CD4+ Helper and Regulatory T Cells Elicited by In vitro Peptide Stimulation. Cancer Res. 65: 1577-1586 [Abstract] [Full Text]  
• van Dinten, L. C., Pul, N., van Nieuwpoort, A. F., Out, C. J., Jager, M. J., van den Elsen, P. J. (2005). Uveal and Cutaneous Melanoma: Shared Expression Characteristics of Melanoma-Associated Antigens. IOVS 46: 24-30 [Abstract] [Full Text]  
• Vogt, A., Chuang, P.-T., Hebert, J., Hwang, J., Lu, Y., Kopelovich, L., Athar, M., Bickers, D. R., Epstein, E. H. Jr. (2004). Immunoprevention of Basal Cell Carcinomas with Recombinant Hedgehog-interacting Protein. JEM 199: 753-761 [Abstract] [Full Text]  
• Goldszmid, R. S., Idoyaga, J., Bravo, A. I., Steinman, R., Mordoh, J., Wainstok, R. (2003). Dendritic Cells Charged with Apoptotic Tumor Cells Induce Long-Lived Protective CD4+ and CD8+ T Cell Immunity against B16 Melanoma. J. Immunol. 171: 5940-5947 [Abstract] [Full Text]  
• de Rijke, B., Fredrix, H., Zoetbrood, A., Scherpen, F., Witteveen, H., de Witte, T., van de Wiel-van Kemenade, E., Dolstra, H. (2003). Generation of autologous cytotoxic and helper T-cell responses against the B-cell leukemia-associated antigen HB-1: relevance for precursor B-ALL-specific immunotherapy. Blood 102: 2885-2891 [Abstract] [Full Text]  
• Negroiu, G., Dwek, R. A., Petrescu, S. M. (2003). The Inhibition of Early N-Glycan Processing Targets TRP-2 to Degradation in B16 Melanoma Cells. J. Biol. Chem. 278: 27035-27042 [Abstract] [Full Text]  
• Matsui, K., O'Mara, L. A., Allen, P. M. (2003). Successful elimination of large established tumors and avoidance of antigen-loss variants by aggressive adoptive T cell immunotherapy. Int Immunol 15: 797-805 [Abstract] [Full Text]  
• Takeuchi, H., Kuo, C., Morton, D. L., Wang, H.-J., Hoon, D. S. B. (2003). Expression of Differentiation Melanoma-associated Antigen Genes Is Associated with Favorable Disease Outcome in Advanced-Stage Melanomas. Cancer Res. 63: 441-448 [Abstract] [Full Text]  
• Espinoza-Delgado, I. (2002). Cancer Vaccines. The Oncologist 7: 20-33 [Abstract] [Full Text]  
• Wang, H. Y., Zhou, J., Zhu, K., Riker, A. I., Marincola, F. M., Wang, R.-F. (2002). Identification of a Mutated Fibronectin As a Tumor Antigen Recognized by CD4+T Cells: Its Role in Extracellular Matrix Formation and Tumor Metastasis. JEM 195: 1397-1406 [Abstract] [Full Text]  
• Egilmez, N. K., Hess, S. D., Chen, F.-A., Takita, H., Conway, T. F., Bankert, R. B. (2002). Human CD4+ Effector T Cells Mediate Indirect Interleukin-12- and Interferon-{gamma}-dependent Suppression of Autologous HLA-negative Lung Tumor Xenografts in Severe Combined Immunodeficient Mice. Cancer Res. 62: 2611-2617 [Abstract] [Full Text]  
• Khong, H. T., Rosenberg, S. A. (2002). Pre-Existing Immunity to Tyrosinase-Related Protein (TRP)-2, a New TRP-2 Isoform, and the NY-ESO-1 Melanoma Antigen in a Patient with a Dramatic Response to Immunotherapy. J. Immunol. 168: 951-956 [Abstract] [Full Text]  
• Kiniwa, Y., Fujita, T., Akada, M., Ito, K., Shofuda, T., Suzuki, Y., Yamamoto, A., Saida, T., Kawakami, Y. (2001). Tumor Antigens Isolated from a Patient with Vitiligo and T-Cell-infiltrated Melanoma. Cancer Res. 61: 7900-7907 [Abstract] [Full Text]  
• Sutmuller, R. P.M., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N.M., Wildenberg, M. E., Allison, J. P., Toes, R. E.M., Offringa, R., Melief, C. J.M. (2001). Synergism of Cytotoxic T Lymphocyte-Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses. JEM 194: 823-832 [Abstract] [Full Text]  
• Niethammer, A. G., Xiang, R., Ruehlmann, J. M., Lode, H. N., Dolman, C. S., Gillies, S. D., Reisfeld, R. A. (2001). Targeted Interleukin 2 Therapy Enhances Protective Immunity Induced by an Autologous Oral DNA Vaccine against Murine Melanoma. Cancer Res. 61: 6178-6184 [Abstract] [Full Text]  
• Eck, S. C., Turka, L. A. (2001). Adoptive Transfer Enables Tumor Rejection Targeted against a Self-Antigen without the Induction of Autoimmunity. Cancer Res. 61: 3077-3083 [Abstract] [Full Text]  
• Jäger, D., Stockert, E., Güre, A. O., Scanlan, M. J., Karbach, J., Jäger, E., Knuth, A., Old, L. J., Chen, Y.-T. (2001). Identification of a Tissue-specific Putative Transcription Factor in Breast Tissue by Serological Screening of a Breast Cancer Library. Cancer Res. 61: 2055-2061 [Abstract] [Full Text]  
• Kawakami, Y., Wang, X., Shofuda, T., Sumimoto, H., Tupesis, J. P., Fitzgerald, E., Rosenberg, S. A. (2001). Isolation of a New Melanoma Antigen, MART-2, Containing a Mutated Epitope Recognized by Autologous Tumor-Infiltrating T Lymphocytes. J. Immunol. 166: 2871-2877 [Abstract] [Full Text]  
• Bellone, M., Cantarella, D., Castiglioni, P., Crosti, M. C., Ronchetti, A., Moro, M., Garancini, M. P., Casorati, G., Dellabona, P. (2000). Relevance of the Tumor Antigen in the Validation of Three Vaccination Strategies for Melanoma. J. Immunol. 165: 2651-2656 [Abstract] [Full Text]  
• Zeng, G., Touloukian, C. E., Wang, X., Restifo, N. P., Rosenberg, S. A., Wang, R.-F. (2000). Identification of CD4+ T Cell Epitopes from NY-ESO-1 Presented by HLA-DR Molecules. J. Immunol. 165: 1153-1159 [Abstract] [Full Text]  
• Jäger, D., Stockert, E., Jäger, E., Güre, A. O., Scanlan, M. J., Knuth, A., Old, L. J., Chen, Y.-T. (2000). Serological Cloning of a Melanocyte rab Guanosine 5'-Triphosphate-binding Protein and a Chromosome Condensation Protein from a Melanoma Complementary DNA Library. Cancer Res. 60: 3584-3591 [Abstract] [Full Text]  
• Colella, T. A., Bullock, T. N.J., Russell, L. B., Mullins, D. W., Overwijk, W. W., Luckey, C. J., Pierce, R. A., Restifo, N. P., Engelhard, V. H. (2000). Self-Tolerance to the Murine Homologue of a Tyrosinase-Derived Melanoma Antigen: Implications for Tumor Immunotherapy. JEM 191: 1221-1232 [Abstract] [Full Text]  
• Ludewig, B., Ochsenbein, A. F., Odermatt, B., Paulin, D., Hengartner, H., Zinkernagel, R. M. (2000). Immunotherapy with Dendritic Cells Directed against Tumor Antigens Shared with Normal Host Cells Results in Severe Autoimmune Disease. JEM 191: 795-804 [Abstract] [Full Text]  
• Bowne, W. B., Srinivasan, R., Wolchok, J. D., Hawkins, W. G., Blachere, N. E., Dyall, R., Lewis, J. J., Houghton, A. N. (1999). Coupling and Uncoupling of Tumor Immunity and Autoimmunity. JEM 190: 1717-1722 [Abstract] [Full Text]  
• Nishimura, M. I., Avichezer, D., Custer, M. C., Lee, C. S., Chen, C., Parkhurst, M. R., Diamond, R. A., Robbins, P. F., Schwartzentruber, D. J., Rosenberg, S. A. (1999). MHC Class I-restricted Recognition of a Melanoma Antigen by a Human CD4+ Tumor Infiltrating Lymphocyte. Cancer Res. 59: 6230-6238 [Abstract] [Full Text]  
• Wang, F., Bade, E., Kuniyoshi, C., Spears, L., Jeffery, G., Marty, V., Groshen, S., Weber, J. (1999). Phase I Trial of a MART-1 Peptide Vaccine with Incomplete Freund's Adjuvant for Resected High-Risk Melanoma. Clin. Cancer Res. 5: 2756-2765 [Abstract] [Full Text]  
• Ronsin, C., Chung-Scott, V., Poullion, I., Aknouche, N., Gaudin, C., Triebel, F. (1999). A Non-AUG-Defined Alternative Open Reading Frame of the Intestinal Carboxyl Esterase mRNA Generates an Epitope Recognized by Renal Cell Carcinoma-Reactive Tumor-Infiltrating Lymphocytes In Situ. J. Immunol. 163: 483-490 [Abstract] [Full Text]  
• Wang, R., Wang, X., Atwood, A. C., Topalian, S. L., Rosenberg, S. A. (1999). Cloning Genes Encoding MHC Class II-Restricted Antigens: Mutated CDC27 as a Tumor Antigen. Science 284: 1351-1354 [Abstract] [Full Text]  
• Wang, R.-F., Wang, X., Rosenberg, S. A. (1999). Identification of a Novel Major Histocompatibility Complex Class II-restricted Tumor Antigen Resulting from a Chromosomal Rearrangement Recognized by CD4+ T Cells. JEM 189: 1659-1668 [Abstract] [Full Text]  
• Pardoll, D. M. (1999). Inducing autoimmune disease to treat cancer. Proc. Natl. Acad. Sci. USA 96: 5340-5342 [Full Text]  
• Greten, T. F., Jaffee, E. M. (1999). Cancer Vaccines. JCO 17: 1047-1047 [Abstract] [Full Text]  
• Reynolds, S. R., Celis, E., Sette, A., Oratz, R., Shapiro, R. L., Johnston, D., Fotino, M., Bystryn, J.-C. (1998). HLA-Independent Heterogeneity of CD8+ T Cell Responses to MAGE-3, Melan-A/MART-1, gp100, Tyrosinase, MC1R, and TRP-2 in Vaccine-Treated Melanoma Patients. J. Immunol. 161: 6970-6976 [Abstract] [Full Text]  
• Kawakami, Y., Robbins, P. F., Wang, X., Tupesis, J. P., Parkhurst, M. R., Kang, X., Sakaguchi, K., Appella, E., Rosenberg, S. A. (1998). Identification of New Melanoma Epitopes on Melanosomal Proteins Recognized by Tumor Infiltrating T Lymphocytes Restricted by HLA-A1, -A2, and -A3 Alleles. J. Immunol. 161: 6985-6992 [Abstract] [Full Text]  
• Dyall, R., Bowne, W. B., Weber, L. W., LeMaoult, J., Szabo, P., Moroi, Y., Piskun, G., Lewis, J. J., Houghton, A. N., Nikolic-Zugic, J. (1998). Heteroclitic Immunization Induces Tumor Immunity. JEM 188: 1553-1561 [Abstract] [Full Text]  
• Wang, R.-F., Johnston, S. L., Zeng, G., Topalian, S. L., Schwartzentruber, D. J., Rosenberg, S. A. (1998). A Breast and Melanoma-Shared Tumor Antigen: T Cell Responses to Antigenic Peptides Translated from Different Open Reading Frames. J. Immunol. 161: 3596-3606 [Abstract] [Full Text]  
• Lupetti, R., Pisarra, P., Verrecchia, A., Farina, C., Nicolini, G., Anichini, A., Bordignon, C., Sensi, M., Parmiani, G., Traversari, C. (1998). Translation of a Retained Intron in Tyrosinase-related Protein (TRP) 2 mRNA Generates a New Cytotoxic T Lymphocyte (CTL)-defined and Shared Human Melanoma Antigen Not Expressed in Normal Cells of the Melanocytic Lineage. JEM 188: 1005-1016 [Abstract] [Full Text]  
• Gueguen, M., Patard, J.-J., Gaugler, B., Brasseur, F., Renauld, J.-C., Van Cangh, P. J., Boon, T., Van den Eynde, B. J. (1998). An Antigen Recognized by Autologous CTLs on a Human Bladder Carcinoma. J. Immunol. 160: 6188-6194 [Abstract] [Full Text]  
• Shichijo, S., Nakao, M., Imai, Y., Takasu, H., Kawamoto, M., Niiya, F., Yang, D., Toh, Y., Yamana, H., Itoh, K. (1998). A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes. JEM 187: 277-288 [Abstract] [Full Text]  
• Wang, R.-F., Johnston, S. L., Southwood, S., Sette, A., Rosenberg, S. A. (1998). Recognition of an Antigenic Peptide Derived from Tyrosinase-Related Protein-2 by CTL in the Context of HLA-A31 and -A33. J. Immunol. 160: 890-897 [Abstract] [Full Text]  
• Le Fur, N., Silvers, W. K., Kelsall, S. R., Mintz, B. (1997). Up-regulation of specific tyrosinase mRNAs in mouse melanomas with the c2j gene substituted for the wild-type tyrosinase allele: Utilization in design of syngeneic immunotherapy models. Proc. Natl. Acad. Sci. USA 94: 7561-7565 [Abstract] [Full Text]  
• Le Fur, N., Kelsall, S. R., Silvers, W. K., Mintz, B. (1997). Selective increase in specific alternative splice variants of tyrosinase in murine melanomas: A projected basis for immunotherapy. Proc. Natl. Acad. Sci. USA 94: 5332-5337 [Abstract] [Full Text]  
• Bloom, M. B., Perry-Lalley, D., Robbins, P. F., Li, Y., El-Gamil, M., Rosenberg, S. A., Yang, J. C. (1997). Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma. JEM 185: 453-460 [Abstract] [Full Text]  
• Zeng, G., Wang, X., Robbins, P. F., Rosenberg, S. A., Wang, R.-F. (2001). CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production. Proc. Natl. Acad. Sci. USA 98: 3964-3969 [Abstract] [Full Text]  
• Xiang, R., Lode, H. N., Chao, T.-H., Ruehlmann, J. M., Dolman, C. S., Rodriguez, F., Whitton, J. L., Overwijk, W. W., Restifo, N. P., Reisfeld, R. A. (2000). An autologous oral DNA vaccine protects against murine melanoma. Proc. Natl. Acad. Sci. USA 97: 5492-5497 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS